142
Participants
Start Date
January 7, 2010
Primary Completion Date
August 23, 2010
Study Completion Date
August 23, 2010
Placebo
Placebo to match GW856553
GS856553
GW586553 7.5mg bid
GSK Investigational Site, Hamar
GSK Investigational Site, Hoersholm
GSK Investigational Site, Odense C
GSK Investigational Site, Trondheim
GSK Investigational Site, Hamburg
GSK Investigational Site, Hamburg
GSK Investigational Site, Schönau
GSK Investigational Site, Lyon
GSK Investigational Site, Paris
GSK Investigational Site, Bois-Guillaume
GSK Investigational Site, Munich
GSK Investigational Site, Boulogne-Billancourt
GSK Investigational Site, Nice
GSK Investigational Site, Leipzg
GSK Investigational Site, Oslo
GSK Investigational Site, Örebro
GSK Investigational Site, Stockholm
Lead Sponsor
GlaxoSmithKline
INDUSTRY